Low levels of high-density lipoprotein cholesterol in patients with atherosclerotic stroke: A prospective cohort study

Atherosclerosis

Volumn 228, Issue 2, 2013, Pages 472-477

  Yeh, Poh Shiow ^a,b   Yang, Chun Ming ^a   Lin, Sheng Hsiang ^c   Wang, Wei Ming ^c   Chen, Po Sheng ^c   Chao, Ting Hsing ^c   Lin, Huey Juan ^a,b   Lin, Kao Chang ^a   Chang, Chia Yu ^a   Cheng, Tain Junn ^a   Li, Yi Heng ^c  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

High density lipoprotein cholesterol; Ischemic stroke; Mortality

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; TRANSIENT ISCHEMIC ATTACK;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; ODDS RATIO; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; TRIGLYCERIDES;

EID: 84878110612     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.03.015     Document Type: Article

References (31)

1. Dhamoon M.S., Tai W., Boden-Albala B., et al. Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke 2007, 38:1752-1758.
2. Elkind M.S. Outcomes after stroke: risk of recurrent ischemic stroke and other events. Am J Med 2009, 122(Suppl. 2):S7-S13.
3. Appelros P., Nydevik I., Viitanen M. Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year. Stroke 2003, 34:122-126.
4. Koton S., Tanne D., Green M.S., Bornstein N.M. Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first national acute stroke Israeli survey (NASIS 2004). Neuroepidemiology 2010, 34:90-96.
5. Imamura T., Doi Y., Arima H., et al. LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 2009, 40:382-388.
6. Kurth T., Everett B.M., Buring J.E., Kase C.S., Ridker P.M., Gaziano J.M. Lipid levels and the risk of ischemic stroke in women. Neurology 2007, 68:556-562.
7. Tanne D., Yaari S., Goldbourt U. High-density lipoprotein cholesterol and risk of ischemic stroke mortality: a 21-year follow-up of 8586 men from the Israeli ischemic heart disease study. Stroke 1997, 28:83-87.
8. Sacco R.L., Benson R.T., Kargman D.E., et al. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAm Med Assoc 2001, 285:2729-2735.
9. Amarenco P., Bogousslavsky J., Callahan A., et al. High-dose atorvastatin after stroke or transient ischemic attack. NEngl J Med 2006, 355:549-559.
10. Navab M., Ananthramaiah G.M., Reddy S.T., et al. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. JLipid Res 2004, 45:993-1007.
11. Barter P.J., Nicholls S., Rye K.A., Anantharamaiah G.M., Navab M., Fogelman A.M. Antiinflammatory properties of HDL. Circ Res 2004, 95:764-772.
12. Mineo C., Deguchi H., Griffin J.H., Shaul P.W. Endothelial and antithrombotic actions of HDL. Circ Res 2006, 98:1352-1364.
13. Paterno R.R.A., Postiglione A., Hubsch A., Andresen I., Lang M.G. Reconstituted high-density lipoprotein exhibits neuroprotection in two rat models of stroke. Cerebrovasc Dis 2004, 17:204-211.
14. Adams H.P., Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
15. Sanossian N., Saver J.L., Kim D., Razinia T., Ovbiagele B. Do high-density lipoprotein cholesterol levels influence stroke severity?. JStroke Cerebrovasc Dis 2006, 15:187-189.
16. Putaala J., Strbian D., Mustanoja S., Haapaniemi E., Kaste M., Tatlisumak T. Functional outcome in young adult ischemic stroke: impact of lipoproteins. Acta Neurol Scand 2013, 127:61-69.
17. Barter P., Gotto A.M., LaRosa J.C., et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. NEngl J Med 2007, 357:1301-1310.
18. Nardi K., Engelter S., Strbian D., et al. Lipid profiles and outcome in patients treated by intravenous thrombolysis for cerebral ischemia. Neurology 2012, 79:1101-1108.
19. Kuwashiro T., Sugimori H., Kamouchi M., Ago T., Kitazono T., Iida M. Lower levels of high-density lipoprotein cholesterol on admission and a recurrence of ischemic stroke: a 12-month follow-up of the Fukuoka Stroke Registry. JStroke Cerebrovasc Dis 2012, 21:561-568.
20. Makihara N., Okada Y., Koga M., et al. Effect of serum lipid levels on stroke outcome after rt-PA therapy: SAMURAI rt-PA registry. Cerebrovasc Dis 2012, 33:240-247.
21. Huxley R.R., Barzi F., Lam T.H., et al. Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: an individual participant data meta-analysis of 23 studies in the Asia-Pacific region. Circulation 2011, 124:2056-2064.
22. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAm Med Assoc 2001, 285:2486-2497.
23. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011, 32:1769-1818.
24. Barter P.J., Rye K.A. Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk. JLipid Res 2012, 53:1755-1766.
25. Russman A.N., Schultz L.R., Zaman I.F., et al. Asignificant temporal and quantitative relationship exists between high-density lipoprotein levels and acute ischemic stroke presentation. JNeurol Sci 2009, 279:53-56.
26. Kargman D.E., Tuck C., Berglund L., et al. Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study. Atherosclerosis 1998, 139:391-399.
27. Aull S., Lalouschek W., Schnider P., Sinzinger H., Uhl F., Zeiler K. Dynamic changes of plasma lipids and lipoproteins in patients after transient ischemic attack or minor stroke. Am J Med 1996, 101:291-298.
28. Zuliani G., Volpato S., Blè A., et al. High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: the InChianti study. Atherosclerosis 2007, 192:384-390.
29. Zuliani G., Romagnoni F., Bollini C., Leoci V., Soattin L., Fellin R. Low levels of high-density lipoprotein cholesterol are a marker of disability in the elderly. Gerontology 1999, 45:317-322.
30. Musha H., Hayashi A., Kida K., et al. Gender difference in the level of high-density lipoprotein cholesterol in elderly Japanese patients with coronary artery disease. Intern Med 2006, 45:241-245.
31. Davis C.E., Williams D.H., Oganov R.G., et al. Sex difference in high density lipoprotein cholesterol in six countries. Am J Epidemiol 1996, 143:1100-1106.